The new year brings a new collaboration for Medipartner.
During the past Corona pandemic, which ran from spring 2020 to May 2022, our client developed several vaccines, helping to bring the virus under control so that life could resume as normal in Belgium. However, the virus and its variants have not disappeared yet, so our client remains committed to developing and producing medication. To ensure that pharmacies in our country receive the necessary information about the different forms of medication and their effects, the listed pharmaceutical company is calling on Medipartner.
Next Monday, 9 January 2023, a team of 4 Medical Educators will start working within Medipartner to provide the necessary information. We thank our client for their trust and look forward to a constructive cooperation.